Search for other papers by Sylvie Hiéronimus in
Google Scholar
PubMed
Search for other papers by Patricia Ferrari in
Google Scholar
PubMed
Search for other papers by Jocelyn Gal in
Google Scholar
PubMed
Search for other papers by Frédéric Berthier in
Google Scholar
PubMed
Search for other papers by Stéphane Azoulay in
Google Scholar
PubMed
Search for other papers by André Bongain in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, University Nice-Sophia-Antipolis, Nice, France
Search for other papers by Patrick Fénichel in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, University Nice-Sophia-Antipolis, Nice, France
Search for other papers by Françoise Brucker-Davis in
Google Scholar
PubMed
level [ 1 , 2 ], serum thyroglobulin (Tg) has been proposed as a marker of ID [ 3 ], including in newborns [ 4 , 5 ]. Maternal iodine supplementation has been shown to improve maternal and cord blood (CB) thyroid tests in areas of moderate and severe ID
Search for other papers by John H. Lazarus in
Google Scholar
PubMed
supplements during gestation [ 14 ]. Interestingly, the frequency of elevated neonatal thyroid-stimulating hormone levels was still low (3%) in this population [ 15 ]. In Denmark, while the majority of pregnant women took iodine-containing supplements, the
fortified by a universally set minimum amount of iodine. Adopting an agreed universal minimum concentration of salt iodine will allow the safe and effective improvement in the consumption of iodine throughout the EU. Individual member states would be allowed
Search for other papers by Bing Han in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Jie Yu in
Google Scholar
PubMed
Search for other papers by Jing Cheng in
Google Scholar
PubMed
Search for other papers by Yingchao Chen in
Google Scholar
PubMed
Search for other papers by Chunfang Zhu in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
status has been determined to be more than adequate [ 7 ]. In another survey reported by the institute of iodine deficiency disorders, national median urine iodine concentration was 238.6, 184.4, and 174.4 μg/L in children, pregnant women, and lactating
Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France
Search for other papers by Françoise Brucker-Davis in
Google Scholar
PubMed
Search for other papers by Patricia Panaïa-Ferrari in
Google Scholar
PubMed
Search for other papers by Jocelyn Gal in
Google Scholar
PubMed
Institut National de la Recherche Médicale, UMR U895, Université Nice-Sophia Antipolis, Nice, France
Search for other papers by Patrick Fénichel in
Google Scholar
PubMed
Search for other papers by Sylvie Hiéronimus in
Google Scholar
PubMed
4) levels after the first trimester [ 1 ], which is considered by some as pathological, despite normal TSH concentration, and led to the concept of maternal hypothyroxinemia [ 2 ]. The definition of maternal hypothyroxinemia is usually set below the
Search for other papers by Katarzyna Pelewicz in
Google Scholar
PubMed
Search for other papers by Rafał Wolny in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by Piotr Miśkiewicz in
Google Scholar
PubMed
of free iodine and 15–60 g of bound iodine [ 2 ], an amount well above the acceptable upper level. In the case of excess iodine, thyroid discontinues the release of hormones (the acute Wolff-Chaikoff effect). This effect is usually transient, although
Search for other papers by Emilio Fiore in
Google Scholar
PubMed
Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Search for other papers by Paolo Vitti in
Google Scholar
PubMed
of iodine-induced thyrotoxicosis in subjects with preexisting autonomous multinodular goiter. This condition is transient and correlated to the level of iodine deficiency and the amount of iodine administered. In 1980, when in Switzerland the salt
Search for other papers by Christiaan F. Mooij in
Google Scholar
PubMed
Search for other papers by Nitash Zwaveling-Soonawala in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by A.S. Paul van Trotsenburg in
Google Scholar
PubMed
, while the other 2 patients reached normalization of FT3 only after 14 days of treatment. However, the use of amiodarone, an antiarrhythmic drug containing a high concentration of iodine, has not been described previously in the preoperative treatment
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
National Board of Health, Nuuk, Greenland
Search for other papers by Paneeraq Noahsen in
Google Scholar
PubMed
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland
Search for other papers by Karsten F Rex in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Queen Ingrid’s Health Care Centre, Nuuk, Greenland
Search for other papers by Gert Mulvad in
Google Scholar
PubMed
Search for other papers by Hans Christian Florian-Sørensen in
Google Scholar
PubMed
Search for other papers by Michael Lynge Pedersen in
Google Scholar
PubMed
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland
Department of Geriatric Medicine, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Introduction Iodine intake level is important for the occurrence of thyroid disorders ( 1 ). Low iodine intake is associated with an increased risk of goiter, thyroid dysfunction, and developmental brain damage if the iodine deficiency is
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Department of Nuclear Medicine, Irmandade Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil
Search for other papers by Rosália P. Padovani in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Search for other papers by Teresa S. Kasamatsu in
Google Scholar
PubMed
Search for other papers by Beatriz C.G. Freitas in
Google Scholar
PubMed
Search for other papers by Marilia M.S. Marone in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Search for other papers by Cleber P. Camacho in
Google Scholar
PubMed
Thyroid Diseases Center, Instituto Israelita de Ensino e Pesquisa Albert Einstein, Brazil
Search for other papers by Rosa Paula M. Biscolla in
Google Scholar
PubMed
challenging factor is the iodine uptake capacity of thyroid cancer tissue, which is poorer than that of normal thyroid cells [ 4 ]. In addition, to maximize the RAI uptake by residual thyroid remnants, persistent disease, or metastases, TSH levels must be